OTC and FDA Registration
Friday, September 6, 2019
ZELAPAR (Selegiline Hydrochloride) Tablet, Orally Disintegrating [Valeant Pharmaceuticals North America LLC]
Updated Date: Tue, 03 Sep 2019 00:00:00 EDT
from
https://fda.report/DailyMed/380d7717-2a79-42f3-a712-efe5e7696ba0&version=9
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment